Recent developments with Axogen Inc (AXGN) have led to the company’s beta value being reach 1.07 cents.

Sana Meer

A new trading day began on Monday, with Axogen Inc (NASDAQ: AXGN) stock price down -4.03% from the previous day of trading, before settling in for the closing price of $17.88. AXGN’s price has ranged from $9.22 to $21.00 over the past 52 weeks.

A company in the Healthcare sector has jumped its sales by 21.24% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 106.58%. With a float of $43.53 million, this company’s outstanding shares have now reached $45.77 million.

Axogen Inc (AXGN) Insider and Institutional Ownership

As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Axogen Inc is 5.40%, while institutional ownership is 87.85%. The most recent insider transaction that took place on Oct 03 ’25, was worth 265,283. In this transaction Director of this company sold 14,571 shares at a rate of $18.21, taking the stock ownership to the 2,293 shares. Before that another transaction happened on Oct 03 ’25, when Company’s Director sold 7,600 for $18.21, making the entire transaction worth $138,367. This insider now owns 0 shares in total.

Axogen Inc (AXGN) Latest Financial update

In its latest quarterly report, released on 9/30/2024, the company reported earnings of 0.07 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.09 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 106.58% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 86.45% during the next five years compared to 21.24% growth over the previous five years of trading.

Axogen Inc (NASDAQ: AXGN) Trading Performance Indicators

Here are Axogen Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.67. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.88. Likewise, its price to free cash flow for the trailing twelve months is 159.83.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.11, a number that is poised to hit 0.07 in the next quarter and is forecasted to reach 0.48 in one year’s time.

Technical Analysis of Axogen Inc (AXGN)

Let’s dig in a bit further. During the last 5-days, its volume was 1.14 million. That was better than the volume of 0.84 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 57.97%.

During the past 100 days, Axogen Inc’s (AXGN) raw stochastic average was set at 84.30%, which indicates a significant increase from 28.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.68 in the past 14 days, which was higher than the 0.65 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $15.70, while its 200-day Moving Average is $15.27. However, in the short run, Axogen Inc’s stock first resistance to watch stands at $17.76. Second resistance stands at $18.36. The third major resistance level sits at $18.68. If the price goes on to break the first support level at $16.84, it is likely to go to the next support level at $16.52. The third support level lies at $15.92 if the price breaches the second support level.

Axogen Inc (NASDAQ: AXGN) Key Stats

With a market capitalization of 789.58 million, the company has a total of 46,013K Shares Outstanding. Currently, annual sales are 187,340 K while annual income is -9,960 K. The company’s previous quarter sales were 56,660 K while its latest quarter income was 580 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.